Systemic Lupus Erythematosus : Recent Concepts in Genomics, Pathogenetic Mechanisms, and Therapies

Abstract EN

Systemic lupus erythematosus (SLE) is a chronic multisystem autoimmune disorder associated with multiple immunological abnormalities and a wide range of clinical manifestations.

Recent progress in genetics has expanded the number of the genes associated with SLE to more than 20 in number and has contributed to improvement of understanding of the pathogenesis of the disease.

This has enhanced the development of novel therapeutic targets and biomarkers for individualized and tailor-made clinical management of lupus patients.

Despite this knowledge, however, it is a challenge to fully understand the genetic pathogenesis of the disease.

The present paper describes the current concepts in the mechanisms, genomics, and pathogenesis of SLE and their implications for management of the disorder.

The potential role of gene therapy, biological agents, intravenous immunoglobulin, anti-inflammatory cytokines, and cytokine inhibitors is discussed.